Nine Months in Space Raises Concerns Over Cancer, Brain Damage, and More NASA astronauts Sunita Williams and Barry “Butch” Wilmore, who have been stranded aboard the International Space Station (ISS) for more than nine months,...

Doctors express optimism but stress continued monitoring Rome, Italy – Pope Francis has reached the two-week mark in his hospitalization for pneumonia, with doctors indicating that he has passed the most critical stage of his...

New research suggests current B12 recommendations may be insufficient for brain health A recent study suggests that what is currently considered a “normal” level of vitamin B12 may not be enough to prevent dementia. Researchers...

A mysterious and fatal disease is sweeping through the Democratic Republic of Congo, claiming at least 53 lives since the outbreak began last month in the northwest region. This area is already grappling with a...

Revolutionary Gene Therapy Restores Vision in Children Born Blind In a groundbreaking medical achievement, British doctors have become the first in the world to cure blindness in children born with a rare genetic condition through...

Experts have uncovered a significant connection between walking patterns and the onset of dementia, highlighting a lesser-known symptom that could serve as an early warning sign of cognitive decline. With nearly 6.7 million individuals in...

In a groundbreaking revelation, Dr. Stuart Hameroff, an anesthesiologist and professor at the University of Arizona, has proposed that a surge of energy observed in the brains of dying patients may signify the “soul leaving...

Pope Francis is currently hospitalized in Rome as he battles a complex respiratory tract infection, which has raised concerns about his health. The Vatican announced on Monday that the 88-year-old pontiff is suffering from a...

FDA classifies recall as second-highest risk level A nationwide recall has been issued for over 2 million cases of MadeGood granola bars following concerns over potential metal contamination. The Food and Drug Administration (FDA) has...

First-of-its-kind medication shows significant cardiovascular benefits A groundbreaking clinical trial has found that sotagliflozin—a drug originally approved for type 2 diabetes and kidney disease—can also significantly lower the risk of heart attacks and strokes. The...